The company
Vanguard Morningstar Mid-Cap Growth ETF
VOT · NYSE Arca · fund
VOT stood above a rising 150-day average in 25 of the last 52 weekly readings, including each of the last 1 week. It is 0.6% above that average now.
Statistics
- Rotation
- not in the set
- Weeks in an uptrend
- 1 in a row
- Officials’ trades on record
- 21
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 25 of 52 weeks.
Money in and out
Open-market buys above the line and sales below, in dollars. Not yet read: institutions.
Congress and officials
21 disclosed lines: House 21, Senate 0, executive 0; 3 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Thomas MacArthur House: U.S. House ClerkNJ03 | bought | $15k–$50k | 17 Aug 2017filed 7 Sep 2017 |
| Thomas MacArthur House: U.S. House ClerkNJ03 | sold | $1k–$15k | 16 May 2017filed 17 Jun 2017 |
| Thomas MacArthur House: U.S. House ClerkNJ03 | sold | $1k–$15k | 16 May 2017filed 17 Jun 2017 |
| Thomas MacArthur House: U.S. House ClerkNJ03 | sold | $15k–$50k | 16 May 2017filed 17 Jun 2017 |
| Thomas MacArthur House: U.S. House ClerkNJ03 | bought | $1k–$15k | 9 Jan 2017filed 8 Feb 2017 |
| Virginia Foxx House: U.S. House ClerkNC05 | soldjoint | $50k–$100k | 9 Dec 2016filed 5 Jan 2017 |
| Raúl M. Grijalva House: U.S. House ClerkAZ03 | bought | $1k–$15k | 20 Sep 2016filed 5 Oct 2016 |
| Thomas MacArthur House: U.S. House ClerkNJ03 | sold | $50k–$100k | 25 Jul 2016filed 6 Aug 2016 |
| Thomas MacArthur House: U.S. House ClerkNJ03 | sold | $15k–$50k | 1 Feb 2016filed 3 Mar 2016 |
| Thomas MacArthur House: U.S. House ClerkNJ03 | bought | $1k–$15k | 29 Sep 2015filed 8 Oct 2015 |
| Virginia Foxx House: U.S. House ClerkNC05 | boughtjoint | $50k–$100k | 21 Jul 2015filed 12 Aug 2015 |
| Thomas MacArthur House: U.S. House ClerkNJ03 | boughtjoint | $100k–$250k | 2 Jun 2015filed 11 Jul 2015 |
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Still reading this part; it fills in a moment.
News
No headline names it lately.
Everyone who traded it
Same industry
No other stock in its industry this week.
Government contracts
No federal award is tied to it.
From its SEC filings
No ratio computed from its SEC filings yet.
Analyst forecasts
No analyst forecasts yet.